Skip to content
Screener

Restricted Cash at other companies

OrthoPediatrics logo
OrthoPediatricsKIDS
$2.05M+0.1%
Xtant Medical Holdings logo
Xtant Medical HoldingsXTNT
$347K+204%
Carlsmed, Inc. logo
Carlsmed, Inc.CARL
$100K0.0%
ClearPoint Neuro logo
ClearPoint NeuroCLPT
$923K
Boston Scientific logo
Boston ScientificBSX
$71M-31.1%
VAT
InnovateVATE
$600K

Other financials

Income statement

See full
Revenue$210.9M+3.8%
Gross profit$149.7M+7.3%
Operating income-$8.1M+49.2%
Net income-$15.8M-12.2%
EPS (diluted)-$0.39-8.3%

Balance sheet

See full
Cash & equivalents$103.8M+58.2%
Total debt$237.7M+33.3%
Total equity$429.2M-6.4%
Total assets$873.0M+4.3%

Cash flow

See full
Operating cash flow-$6.2M-153%
CapEx$12.6M+77.9%
Free cash flow-$18.9M

Valuation

See full
Market cap$417.92M-18.2%
Enterprise value$551.79M-11.5%
P/S0.5×-0.1×

Profitability

See full
Gross margin71.3%+3.9pp
Operating margin-4.8%-1.8pp
Net margin-7.4%-2.5pp
FCF margin-9.7%-1.8pp

Returns & leverage

See full
Return on equity-13.9%-4.2pp
Debt / equity0.6×+0.2×
Current ratio2.8×+0.2×

Where this comes from

Reported directly by Orthofix Medical Inc. in its filing.

Tagged under the XBRL concept us-gaap:RestrictedCashCurrent.

The source filing: Orthofix Medical Inc.’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 7:06 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-333822
(U.S. Dollars, in thousands, except par value data)June 30,2026December 31,2025
Assets
Current assets
Cash and cash equivalents$103,810$82,025
Restricted cash5953,090
Accounts receivable, net of allowances of $10,563 and $8,308, respectively135,818135,746
Inventories184,475172,319
Prepaid expenses and other current assets21,43423,667
Total current assets446,132416,847

Item 1. Financial Statements

FAQ

What is Orthofix Medical Inc.'s restricted cash?
Orthofix Medical Inc. (OFIX) reported restricted cash of $595K in Q2 2026.
How has Orthofix Medical Inc.'s restricted cash changed year-over-year?
Orthofix Medical Inc.'s restricted cash decreased by 80.7% year-over-year, from $3.08M to $595K.
What is the long-term trend for Orthofix Medical Inc.'s restricted cash?
Over 3 years (2020 to 2025), Orthofix Medical Inc.'s restricted cash has grown at a 80.0% compound annual growth rate (CAGR), from $530K to $3.09M.
What does restricted cash mean?
Cash restricted for specific purposes by contractual, regulatory, or legal requirements — not available for general corporate use.

Ask your AI about Orthofix Medical Inc.'s restricted cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude